Gunther Birznieks

Insider Reports History

Entity
Individual
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC
Signature
/s/ Gunther Birznieks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gunther Birznieks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. SVP, Business Development Common Stock 314K $1.3M $4.13 Mar 5, 2024 Direct

Insider Reports Filed by Gunther Birznieks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. Mar 4, 2024 2 -$73.4K 4 Mar 6, 2024 SVP, Business Development
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2024 1 $0 4 Feb 21, 2024 SVP, Business Development
VNDA Vanda Pharmaceuticals Inc. Mar 2, 2023 2 -$105K 4 Mar 6, 2023 SVP, Business Development
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 SVP, Business Development
VNDA Vanda Pharmaceuticals Inc. Aug 26, 2022 2 $3.9K 4 Aug 29, 2022 SVP, Business Development
VNDA Vanda Pharmaceuticals Inc. Feb 28, 2022 4 -$175K 4 Mar 2, 2022 SVP, Business Development